Jan Mattsson co-founded Albireo in 2008. He has more than 20 years of experience in the pharmaceutical industry, covering a range of functions including R&D, business development, R&D operations and management. Prior to co-founding Albireo, he held various project leader and management positions at AstraZeneca, primarily in gastrointestinal R&D. Dr. Mattsson holds a B.Sc. in chemistry and a Ph.D. in biochemistry from University of Gothenburg.